Methods: C57BL/6 mice were divided into two groups: control group with normal diet, and obese group fed with 60% high fat diet. All mice were intubated and mechanically ventilated for 6 h. Tidal volume was set at low tidal volume (~0.012 mL/gm) and high tidal volume (~0.024 mL/ gm), respectively. Following it, bronchoalveolar lavage fluid (BALF) were collected and sent for analysis.
Results: Ventilator induced lung injury is attenuated in diet induced obese mice. Control group with VILI expressed more M1-polarization (F4/80+ CD11c+ CD206 − CD38+) and it's less expressed in dietinduced obesity (DIO) mice group.
Conclusion:
Ventilator induced lung injury is attenuated in DIO mice, probably resulted from less M1-polarization of alveolar macrophages. 
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Background and Aims: Previously, we reported that nanosized nickel oxide (NiO) and cerium oxide (CeO 2 ) induced persistent pulmonary inflammation of rat by intratracheal administration with histopathological analysis and BALF analysis including neutrophilic number and cytokine expressions but nanosized titanium dioxide (TiO 2 ) and zinc Oxide (ZnO) did not. This time, we performed microarray analysis with mRNA using rat lung tissue. The objective of this study is to identify new genes which is useful for evaluating persistent pulmonary inflammation induced by nanoparticles.
Methods:
The nanosized NiO of 1.0 mg dispersed in distilled water (0.4 mL) were intratracheally administered to each 5 rats. Total RNA was purified from rat lung at 3 days, 1 week, 1 month after administration. The microarray analysis with mRNA was performed using mixed total RNA in the 5 rats administrated with 1.0 mg NiO after 1 month. Five mRNAs with increased expression were selected and expression levels of these genes in lung tissues on 3 days, 1 week, 1 month after administration of four kinds of nanoparticles (TiO 2 , ZnO, CeO 2 and NiO) were quantified by real-time PCR. The average ratio between the administration group and the control group was determined for five genes, and the number of genes whose mRNA expression level increased 5-fold or more or 10-fold or more was determined.
Results: Among the five genes, the number of genes increased by 10 times or more after administration of 1 mg of TiO 2 , ZnO, CeO 2 and NiO was 0, 0, 3 and 5 genes after 3 days, 0, 0, 4 and 5 genes after one week, 0, 0, 5 and 4 genes after 1 month, respectively.
Conclusion:
It was suggested that persistent pulmonary inflammation by nanoparticles could be predicted within 1 month after intratracheal administration by analyzing the expression levels of five genes in the lung tissue. Background and Aims: Neutrophilic airway inflammation is insensitive to steroids and is thereby considered as a substantial clinical problem. Recent advances in the field of immunometabolism support the concept that Th1, Th2, and Th17 cells utilize large amounts of glucose and exhibits increased aerobic glycolysis to meet their energetic and anabolic demands, whereas Treg cells primarily use fatty acid oxidation. Pyruvate dehydrogenase kinases (PDKs) are gate-keeping enzymes for regulating aerobic glycolysis and inhibition of PDKs can suppress the metabolic process. This study aimed to investigate the effect of dichloroaceate (DCA), a known PDK inhibitor, on neutrophilic airway inflammation.
Methods: Mouse model of neutrophil-dominated airway inflammation was used in this study to test the effect of DCA in vivo. Inflammatory cell infiltration in the lungs and goblet cell hyperplasia were determined using histological staining. Total and differential cell counts were evaluated in the bronchoalveolar lavage (BAL) and mRNA expression of cytokines in the lungs was analyzed by real-time PCR analysis. In addition, responses of T cell subsets in lymph nodes were detected by FACS analysis.
Results: Histological staining showed that treatment with DCA ameliorates inflammatory cell infiltration into lung tissue and goblet cell hyperplasia. BAL cells from DCA-treated mice showed less infiltration of total inflammatory cells and lower neutrophil and eosinophil counts compared with those in control mice. In addition, DCA significantly decreased mRNA expression of IL-4 and IL-17A in lung tissues of mice with neutrophilic asthma, whereas IFN-gamma expression was not changed. IL-10 expression was slightly increased by DCA treatment, although there was no statistical significance. Moreover, FACS analysis on lung-draining lymph nodes showed that DCA significantly decreased Th2 and Th17 populations and increased Treg population, whereas Th1 population was not affected.
In conclusion, these findings suggest that DCA ameliorates neutrophilic airway inflammation through suppressing Th17 population and inducing Treg population. 
